Market Overview:
United States artificial intelligence in healthcare market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 108.37 Billion by 2032, exhibiting a growth rate (CAGR) of 43.52% during 2024-2032. The growing demand for valuable tools among healthcare professionals to provide evidence-based insights and recommendations derived from comprehensive data analysis, thereby contributing to informed and efficient decision-making processes, is primarily driving the market growth.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 4.2 Billion |
Market Forecast in 2032
|
US$ 108.37 Billion |
Market Growth Rate 2024-2032 |
43.52% |
Artificial intelligence (AI) in healthcare refers to the utilization of intelligent algorithms and computational models to scrutinize intricate medical data, contribute to diagnosis and treatment, and bolster decision-making processes within the healthcare domain. This involves a diverse array of AI techniques, such as machine learning (ML), natural language processing (NLP), computer vision, and expert systems. The application of AI in healthcare involves the thorough analysis of extensive patient data, encompassing electronic health records (EHR), medical images, and genomic data, aiming to discern patterns and formulate predictions. In line with this, the overarching goal is to facilitate early disease detection, devise personalized treatment plans, and offer support in clinical decision-making.Top of Form
United States Artificial Intelligence in Healthcare Market Trends:
The United States artificial intelligence in healthcare market stands at the forefront of technological innovation, integrating advanced algorithms and computational models to revolutionize medical practices. This dynamic market leverages various AI techniques, including machine learning, natural language processing, computer vision, and expert systems, to analyze complex medical data such as electronic health records (EHR), medical images, and genomic information. AI's application in healthcare is multifaceted, contributing to early disease detection, personalized treatment planning, and clinical decision support. Additionally, the demand for artificial intelligence solutions in healthcare is escalating, driven by the pursuit of enhanced diagnostic accuracy, treatment efficacy, and operational efficiency. As the market expands, AI plays a pivotal role in supporting healthcare professionals by providing evidence-based insights and recommendations derived from extensive data analysis. Furthermore, the transformative impact of artificial intelligence in healthcare extends beyond diagnostics and treatment planning, influencing areas such as predictive analytics, precision medicine, and administrative tasks. Apart from this, the country’s commitment to harnessing innovative technologies for the betterment of patient care and the overall efficiency of healthcare delivery is expected to fuel the market growth over the forecasted period.Top of Form
United States Artificial Intelligence in Healthcare Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on offering, technology, application, and end user.
Offering Insights:
- Hardware
- Software
- Services
The report has provided a detailed breakup and analysis of the market based on the offering. This includes hardware, software, and services.
Technology Insights:
- Machine Learning
- Context-Aware Computing
- Natural Language Processing
- Others
A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes machine learning, context-aware computing, natural language processing, and others.
Application Insights:
- Robot-Assisted Surgery
- Virtual Nursing Assistant
- Administrative Workflow Assistance
- Fraud Detection
- Dosage Error Reduction
- Clinical Trial Participant Identifier
- Preliminary Diagnosis
- Others
The report has provided a detailed breakup and analysis of the market based on the application. This includes robot-assisted surgery, virtual nursing assistant, administrative workflow assistance, fraud detection, dosage error reduction, clinical trial participant identifier, preliminary diagnosis, and others.
End User Insights:
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies
- Patients
- Others
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes healthcare providers, pharmaceutical and biotechnology companies, patients, and others.
Regional Insights:
- Northeast
- Midwest
- South
- West
The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
United States Artificial Intelligence in Healthcare Market Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Billion |
Scope of the Report |
Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
- Offering
- Technology
- Application
- End User
- Region
|
Offerings Covered |
Hardware, Software, Services |
Technologies Covered |
Machine Learning, Context-Aware Computing, Natural Language Processing, Others |
Applications Covered |
Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis, Others |
End Users Covered |
Healthcare Providers, Pharmaceutical and Biotechnology Companies, Patients, Others |
Regions Covered |
Northeast, Midwest, South, West |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the United States artificial intelligence in healthcare market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the United States artificial intelligence in healthcare market?
- What is the breakup of the United States artificial intelligence in healthcare market on the basis of offering?
- What is the breakup of the United States artificial intelligence in healthcare market on the basis of technology?
- What is the breakup of the United States artificial intelligence in healthcare market on the basis of application?
- What is the breakup of the United States artificial intelligence in healthcare market on the basis of end user?
- What are the various stages in the value chain of the United States artificial intelligence in healthcare market?
- What are the key driving factors and challenges in the United States artificial intelligence in healthcare?
- What is the structure of the United States artificial intelligence in healthcare market and who are the key players?
- What is the degree of competition in the United States artificial intelligence in healthcare market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States artificial intelligence in healthcare market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the United States artificial intelligence in healthcare market.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States artificial intelligence in healthcare industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.